AMICUS THERAPEUTICS, INC. — Director's Dealing 2018

Oct 11, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMICUS THERAPEUTICS INC (FOLD)
CIK: 0001178879
Period of Report: 2018-10-09

Reporting Person: Clark David Michael (Chief People Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-10-09	Common Stock	A	56012	$0.00	Acquired	57770	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-10-09	Stock Options (right to buy)	$12.84	A	84842	Acquired	2028-10-09	Common Stock (84842)	Direct

Footnotes

F1: Granted in the form of restricted stock units which, upon vesting, are settled in exchange for shares of the Company's common stock. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.

F2: The restricted stock units vest over a four year period with 25% of the total number of shares vesting on the first anniversary of the grant, followed by 25% on each successive grant date anniversary.

F3: These stock options vest and become exercisable in a series of installments. The first installment, which consists of 25% of the total aggregate number of stock options granted, vest and become exercisable on October 9, 2019. The remaining options vest and become exercisable in a series of thirty-five successive monthly installments beginning on November 1, 2019.